Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 112

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 112
---
 redeem such shares, representing approximately 46% of the outstanding public shares of BLAC Common Stock as of May 8, 2024, for a per share redemption price of approximately $10.78, resulting in an aggregate reduction of the amount in the Trust Account by $17,045,763.24, representing approximately 45% of the total amount in the Trust Account. 56 On November 12, 2024, at the annual meeting of the BLAC stockholders, BLAC stockholers approved an amendment to BLAC’s Amended and Retated Certificate of Incorporation (amended as described in the prior to paragraphs) extending the period of time in which BLAC must complete its initial business combination to February 14, 2025 (from November 14, 2024). In connection with the annual meeting, holders of 1,721,469 public shares of BLAC Common Stock elected to redeem such shares, representing approximately 91% of the outstanding public shares of BLAC Common Stock as of November 8, 2024, for a per share redemption price of approximately $11.15, resulting in an aggregate reduction of the amount in the Trust Account by $19,186,266, representing approximately 91% of the total amount in the Trust Account. BLAC cannot guarantee that it will be able to complete the Business Combination within the time period given by its Amended and Restated Certificate of Incorporation (amended as described in the prior paragraphs), or the amount of redemptions that may occur in connection with an amendment to its Amended and Restated Certificate of Incorporation to further extend the date by which BLAC must complete its initial business combination. The fairness opinion obtained by the BLAC M&A Committee will not reflect changes, circumstances, developments or events that may have occurred or may occur after the date of the opinion. Choloc has provided a fairness opinion to the BLAC M&A Committee stating that, as of the date of such opinion, and based upon and subject to the assumptions made, procedures followed, matters considered and qualifications and limitations on the review undertaken, the Business Combination is fair, from a financial point of view, to the BLAC stockholders. The BLAC M&A Committee has not obtained an updated fairness opinion as of the date of this proxy statement/prospectus from Choloc, and the BLAC M&A Committee does not expect to receive an updated fairness opinion prior to the completion of the Business Combination. The opinion does not reflect changes